181 related articles for article (PubMed ID: 36724294)
21. Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
Borgman MP; Ray A; Kolhatkar RB; Sausville EA; Burger AM; Ghandehari H
Pharm Res; 2009 Jun; 26(6):1407-18. PubMed ID: 19225872
[TBL] [Abstract][Full Text] [Related]
22. Targeting cells of the immune system: mannosylated HPMA-LMA block-copolymer micelles for targeting of dendritic cells.
Mohr N; Kappel C; Kramer S; Bros M; Grabbe S; Zentel R
Nanomedicine (Lond); 2016 Oct; 11(20):2679-2697. PubMed ID: 27628185
[TBL] [Abstract][Full Text] [Related]
23. A novel α
Wang F; Li L; Sun W; Li L; Liu Y; Huang Y; Zhou Z
J Drug Target; 2018 Mar; 26(3):231-241. PubMed ID: 28792244
[TBL] [Abstract][Full Text] [Related]
24. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates.
Luo Y; Bernshaw NJ; Lu ZR; Kopecek J; Prestwich GD
Pharm Res; 2002 Apr; 19(4):396-402. PubMed ID: 12033370
[TBL] [Abstract][Full Text] [Related]
26. Charge-Reversible Multifunctional HPMA Copolymers for Mitochondrial Targeting.
Wang F; Sun W; Li L; Li L; Liu Y; Zhang ZR; Huang Y
ACS Appl Mater Interfaces; 2017 Aug; 9(33):27563-27574. PubMed ID: 28762267
[TBL] [Abstract][Full Text] [Related]
27. HPMA-Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer.
Zimel MN; Horowitz CB; Rajasekhar VK; Christ AB; Wei X; Wu J; Wojnarowicz PM; Wang D; Goldring SR; Purdue PE; Healey JH
Mol Cancer Ther; 2017 Dec; 16(12):2701-2710. PubMed ID: 28830983
[TBL] [Abstract][Full Text] [Related]
28. HPMA copolymer-antibody constructs in neoplastic treatment: an overview of therapeutics, targeted diagnostics, and drug-free systems.
Randárová E; Kudláčová J; Etrych T
J Control Release; 2020 Sep; 325():304-322. PubMed ID: 32652110
[TBL] [Abstract][Full Text] [Related]
29. Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers.
Gormley AJ; Larson N; Banisadr A; Robinson R; Frazier N; Ray A; Ghandehari H
J Control Release; 2013 Mar; 166(2):130-8. PubMed ID: 23262203
[TBL] [Abstract][Full Text] [Related]
30. Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells.
David A; Kopecková P; Rubinstein A; Kopecek J
Bioconjug Chem; 2001; 12(6):890-9. PubMed ID: 11716678
[TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of HPMA-copolymers targeted to HER2 expressing pancreatic tumor cells for image guided drug delivery.
Buckway B; Wang Y; Ray A; Ghandehari H
Macromol Biosci; 2014 Jan; 14(1):92-9. PubMed ID: 24038924
[TBL] [Abstract][Full Text] [Related]
32. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells.
David A; Kopecková P; Minko T; Rubinstein A; Kopecek J
Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799
[TBL] [Abstract][Full Text] [Related]
33. Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis.
Nan A; Croft SL; Yardley V; Ghandehari H
J Control Release; 2004 Jan; 94(1):115-27. PubMed ID: 14684276
[TBL] [Abstract][Full Text] [Related]
34. Targeting damaged collagen for intra-articular delivery of therapeutics using collagen hybridizing peptides.
Luke EN; Ratnatilaka Na Bhuket P; Yu SM; Weiss JA
J Orthop Res; 2023 Nov; 41(11):2424-2432. PubMed ID: 37087677
[TBL] [Abstract][Full Text] [Related]
35. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers.
Oupický D; Konák C; Ulbrich K; Wolfert MA; Seymour LW
J Control Release; 2000 Mar; 65(1-2):149-71. PubMed ID: 10699278
[TBL] [Abstract][Full Text] [Related]
36. Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances.
Segal E; Pan H; Benayoun L; Kopečková P; Shaked Y; Kopeček J; Satchi-Fainaro R
Biomaterials; 2011 Jul; 32(19):4450-63. PubMed ID: 21429572
[TBL] [Abstract][Full Text] [Related]
37. The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells.
David A; Kopecková P; Kopecek J; Rubinstein A
Pharm Res; 2002 Aug; 19(8):1114-22. PubMed ID: 12240936
[TBL] [Abstract][Full Text] [Related]
38. Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems.
Lammers T; Peschke P; Kühnlein R; Subr V; Ulbrich K; Debus J; Huber P; Hennink W; Storm G
J Control Release; 2007 Feb; 117(3):333-41. PubMed ID: 17215057
[TBL] [Abstract][Full Text] [Related]
39. HPMA copolymer-modified avidin: immune response.
Hart PR; Kopecková P; Omelyanenko V; Enioutina E; Kopecek J
J Biomater Sci Polym Ed; 2000; 11(1):1-12. PubMed ID: 10680604
[TBL] [Abstract][Full Text] [Related]
40. Correlation of subcellular compartmentalization of HPMA copolymer-Mce6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells.
Tijerina M; Kopecková P; Kopecek J
Pharm Res; 2003 May; 20(5):728-37. PubMed ID: 12751627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
